<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d6ded-7ab9-7b32-bd8d-26e56661a719,g:4c9103ee-e77c-4af2-9103-c7e49e755fa9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.contexttherapeutics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cntx-20260331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.contexttherapeutics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d6ded-7aba-7b1f-97d4-46abce579c97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d6ded-7aba-76ac-916e-f0c964fc9d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d6ded-7aba-7b1f-97d4-46abce579c97" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d6ded-7aba-76ac-916e-f0c964fc9d8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d6ded-7aba-7c87-b17b-3f43b8f32032" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d6ded-7aba-7b1f-97d4-46abce579c97" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d6ded-7aba-7c87-b17b-3f43b8f32032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019d6ded-7aba-7de5-a1b1-d6ca2c5b1e55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019d6ded-7aba-7c32-9e12-1c79a4049405" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d6ded-7aba-7de5-a1b1-d6ca2c5b1e55" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019d6ded-7aba-7c32-9e12-1c79a4049405" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d6ded-7aba-77b0-a005-ab58a92891ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d6ded-7aba-7de5-a1b1-d6ca2c5b1e55" xlink:to="loc_us-gaap_AssetsCurrent_019d6ded-7aba-77b0-a005-ab58a92891ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019d6ded-7aba-7aab-9c4c-bb6628a845d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d6ded-7aba-7de5-a1b1-d6ca2c5b1e55" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019d6ded-7aba-7aab-9c4c-bb6628a845d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d6ded-7aba-737d-8e8a-3a405a008524" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019d6ded-7aba-79ef-a42e-141bca5f03e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d6ded-7aba-737d-8e8a-3a405a008524" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019d6ded-7aba-79ef-a42e-141bca5f03e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019d6ded-7aba-7796-987e-43cd138d841d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d6ded-7aba-737d-8e8a-3a405a008524" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019d6ded-7aba-7796-987e-43cd138d841d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019d6ded-7aba-7774-a192-a55b7ab8bb63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d6ded-7aba-737d-8e8a-3a405a008524" xlink:to="loc_us-gaap_AccountsPayableCurrent_019d6ded-7aba-7774-a192-a55b7ab8bb63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d6ded-7aba-7442-a05a-0b9d1c36e72a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019d6ded-7aba-7c17-ad00-dc27e59ad546" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d6ded-7aba-7442-a05a-0b9d1c36e72a" xlink:to="loc_us-gaap_Liabilities_019d6ded-7aba-7c17-ad00-dc27e59ad546" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019d6ded-7aba-7656-b8bb-86afb95d05f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d6ded-7aba-7442-a05a-0b9d1c36e72a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019d6ded-7aba-7656-b8bb-86afb95d05f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d6ded-7aba-780f-bd57-c49e7b176da5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d6ded-7aba-7442-a05a-0b9d1c36e72a" xlink:to="loc_us-gaap_StockholdersEquity_019d6ded-7aba-780f-bd57-c49e7b176da5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d6ded-7aba-7fbc-9195-0748db8677ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019d6ded-7aba-7fad-b2d3-a477a50ec857" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d6ded-7aba-7fbc-9195-0748db8677ae" xlink:to="loc_us-gaap_PreferredStockValue_019d6ded-7aba-7fad-b2d3-a477a50ec857" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019d6ded-7aba-76b0-9ff1-0dc7d5019bde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d6ded-7aba-7fbc-9195-0748db8677ae" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019d6ded-7aba-76b0-9ff1-0dc7d5019bde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019d6ded-7aba-7d5a-9269-e505cacc3f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d6ded-7aba-7fbc-9195-0748db8677ae" xlink:to="loc_us-gaap_CommonStockValue_019d6ded-7aba-7d5a-9269-e505cacc3f3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d6ded-7aba-7b08-9af6-25eb9afad7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d6ded-7aba-7fbc-9195-0748db8677ae" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d6ded-7aba-7b08-9af6-25eb9afad7f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019d6ded-7aba-74d4-a0d0-f6a7650b0601" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d6ded-7aba-78b0-967b-3dc405ac3e33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d6ded-7aba-74d4-a0d0-f6a7650b0601" xlink:to="loc_us-gaap_LiabilitiesCurrent_019d6ded-7aba-78b0-967b-3dc405ac3e33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019d6ded-7aba-7aa6-96b7-cc21c54bea0d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d6ded-7aba-74d4-a0d0-f6a7650b0601" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019d6ded-7aba-7aa6-96b7-cc21c54bea0d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.contexttherapeutics.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cntx-20260331.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.contexttherapeutics.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d6ded-7aba-71d5-a460-0d4278b1aedd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019d6ded-7aba-7102-bfa3-cc42299f7c35" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d6ded-7aba-71d5-a460-0d4278b1aedd" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019d6ded-7aba-7102-bfa3-cc42299f7c35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_019d6ded-7aba-78fd-9ce9-2b556d48e376" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d6ded-7aba-71d5-a460-0d4278b1aedd" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_019d6ded-7aba-78fd-9ce9-2b556d48e376" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.contexttherapeutics.com/role/CondensedConsolidatedStatementofCashFlowsUnaudited" xlink:type="simple" xlink:href="cntx-20260331.xsd#CondensedConsolidatedStatementofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.contexttherapeutics.com/role/CondensedConsolidatedStatementofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6ded-7aba-79ad-ba89-bdab3b5a1a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_019d6ded-7aba-720a-b91a-b507f9534b71" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6ded-7aba-79ad-ba89-bdab3b5a1a0c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_019d6ded-7aba-720a-b91a-b507f9534b71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d6ded-7aba-7fb3-a7ea-239833f43d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6ded-7aba-79ad-ba89-bdab3b5a1a0c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d6ded-7aba-7fb3-a7ea-239833f43d1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019d6ded-7aba-78dc-9278-c5df119ead70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6ded-7aba-79ad-ba89-bdab3b5a1a0c" xlink:to="loc_us-gaap_ShareBasedCompensation_019d6ded-7aba-78dc-9278-c5df119ead70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d6ded-7aba-7134-b366-7e520b9a5efc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6ded-7aba-79ad-ba89-bdab3b5a1a0c" xlink:to="loc_us-gaap_NetIncomeLoss_019d6ded-7aba-7134-b366-7e520b9a5efc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019d6ded-7aba-76ff-a8f9-6b62e77fa8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6ded-7aba-79ad-ba89-bdab3b5a1a0c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019d6ded-7aba-76ff-a8f9-6b62e77fa8ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019d6ded-7aba-7a28-be12-52ed97d4b70e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6ded-7aba-79ad-ba89-bdab3b5a1a0c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019d6ded-7aba-7a28-be12-52ed97d4b70e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019d6ded-7aba-7517-beec-8486a6a93322" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6ded-7aba-79ad-ba89-bdab3b5a1a0c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019d6ded-7aba-7517-beec-8486a6a93322" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019d6ded-7aba-7482-8093-8f606208e311" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6ded-7aba-79ad-ba89-bdab3b5a1a0c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019d6ded-7aba-7482-8093-8f606208e311" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6ded-7aba-7098-a58a-846e83ca8e39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019d6ded-7aba-7530-b4c9-b4aaa7d1c5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6ded-7aba-7098-a58a-846e83ca8e39" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019d6ded-7aba-7530-b4c9-b4aaa7d1c5c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6ded-7aba-73db-a492-ff513296a038" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d6ded-7aba-764c-9f5f-150cdad21baf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6ded-7aba-73db-a492-ff513296a038" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d6ded-7aba-764c-9f5f-150cdad21baf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d6ded-7aba-7265-9180-ec9252cb0d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6ded-7aba-7aae-a992-ac74d301e419" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d6ded-7aba-7265-9180-ec9252cb0d3b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6ded-7aba-7aae-a992-ac74d301e419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6ded-7aba-76ed-815d-d1f93a50c7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d6ded-7aba-7265-9180-ec9252cb0d3b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6ded-7aba-76ed-815d-d1f93a50c7d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6ded-7aba-7e95-892c-f07659dcec41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d6ded-7aba-7265-9180-ec9252cb0d3b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6ded-7aba-7e95-892c-f07659dcec41" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.contexttherapeutics.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesSummaryofSignificantExpenseCategoriesReviewedByTheCODMDetails" xlink:type="simple" xlink:href="cntx-20260331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesSummaryofSignificantExpenseCategoriesReviewedByTheCODMDetails"/>
  <link:calculationLink xlink:role="http://www.contexttherapeutics.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesSummaryofSignificantExpenseCategoriesReviewedByTheCODMDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d6ded-7b61-721a-9188-e4efe65a0758" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019d6ded-7b61-71d2-aa8f-ac7af63af120" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d6ded-7b61-721a-9188-e4efe65a0758" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019d6ded-7b61-71d2-aa8f-ac7af63af120" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019d6ded-7b61-7862-bdc6-610275e7138d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d6ded-7b61-721a-9188-e4efe65a0758" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019d6ded-7b61-7862-bdc6-610275e7138d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d6ded-7b61-714e-8d0d-8ee5d3a2fda5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d6ded-7b61-721a-9188-e4efe65a0758" xlink:to="loc_us-gaap_OperatingIncomeLoss_019d6ded-7b61-714e-8d0d-8ee5d3a2fda5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d6ded-7b61-79f6-8821-25fbf43c98a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019d6ded-7b61-7267-8f54-ffa2df529ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d6ded-7b61-79f6-8821-25fbf43c98a0" xlink:to="loc_us-gaap_OperatingExpenses_019d6ded-7b61-7267-8f54-ffa2df529ac0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d6ded-7b61-7a64-9c14-7f3d48e26be4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d6ded-7b61-79f6-8821-25fbf43c98a0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d6ded-7b61-7a64-9c14-7f3d48e26be4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019d6ded-7b61-79fb-b2a3-19573dc1e94d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d6ded-7b61-79f6-8821-25fbf43c98a0" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019d6ded-7b61-79fb-b2a3-19573dc1e94d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_019d6ded-7b61-7225-8930-1c336336afcd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d6ded-7b61-79f6-8821-25fbf43c98a0" xlink:to="loc_us-gaap_LaborAndRelatedExpense_019d6ded-7b61-7225-8930-1c336336afcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_019d6ded-7b61-7249-afaf-76e48ff6775c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d6ded-7b61-79f6-8821-25fbf43c98a0" xlink:to="loc_us-gaap_ProfessionalFees_019d6ded-7b61-7249-afaf-76e48ff6775c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.contexttherapeutics.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="cntx-20260331.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.contexttherapeutics.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019d6ded-7b61-7d74-8896-5060bf44a224" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cntx_AccruedResearchAndDevelopmentCostsCurrent_019d6ded-7b61-7351-9d18-e9d3939bd55c" xlink:href="cntx-20260331.xsd#cntx_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d6ded-7b61-7d74-8896-5060bf44a224" xlink:to="loc_cntx_AccruedResearchAndDevelopmentCostsCurrent_019d6ded-7b61-7351-9d18-e9d3939bd55c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_019dd49b-ebab-748c-ae8a-6d2dc3cbb666" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d6ded-7b61-7d74-8896-5060bf44a224" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_019dd49b-ebab-748c-ae8a-6d2dc3cbb666" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019d6ded-7b61-7baa-9375-2b969ec08c40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d6ded-7b61-7d74-8896-5060bf44a224" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019d6ded-7b61-7baa-9375-2b969ec08c40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019d6ded-7b61-78d1-ba59-99439f21c6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d6ded-7b61-7d74-8896-5060bf44a224" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019d6ded-7b61-78d1-ba59-99439f21c6b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019d6ded-7b61-73a6-96c0-34246ad63299" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d6ded-7b61-7d74-8896-5060bf44a224" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019d6ded-7b61-73a6-96c0-34246ad63299" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
